Related Experiment Video

Updated: Aug 12, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Future strategies toward the cure of indolent B-cell malignancies. Molecular genetic approaches

T J Kipps1

  • 1Division of Hematology/Oncology, University of California, San Diego, La Jolla 92093-0663, USA.

Seminars in Hematology
|October 21, 1999
PubMed

Insights

Cancer gene therapy is advancing, targeting genetic defects to boost immune response. Early trials show promise for treating chronic lymphocytic leukemia (CLL) and other indolent B-cell malignancies.

Area of Science:

  • Oncology
  • Genetics
  • Immunology

Background:

  • Cancer arises from somatic mutations in genes controlling cell growth and survival.
  • Genetic discoveries enable targeted therapies exploiting tumor cell genetic alterations.
  • Gene transfer can enhance anti-tumor immune responses against tumor antigens.

Purpose of the Study:

  • To explore immune-based strategies for cancer gene therapy.
  • To evaluate the potential of gene therapy for indolent B-cell malignancies.

Main Methods:

  • Utilizing advances in understanding immune activation mechanics.
  • Developing novel pharmaceutics targeting cancer's genetic machinery.
  • Employing gene transfer to potentiate host immune response.

Main Results:

  • Preliminary findings from a phase I trial are encouraging.
  • Demonstrated potential for immune-based gene therapy in cancer treatment.

Conclusions:

  • Immune-based gene therapy strategies are emerging for cancer treatment.
  • Effective gene therapy for indolent B-cell malignancies may be forthcoming.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...